1. Andrew PA, Velury S, Mann SC, Howell SB (1988) cis-diamminedichloroplatinum (II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res 48:68–73
2. Andrews PA, Albright KD (1992) Mitochondrial defects in cis-diamminedichloroplatinum (II)—resistant human ovarian carcinoma cells. Cancer Res 52:1895–1901
3. Ax W, Soldan M, Koch L, Maser E (2000) Development of duanorubicin resistance in tumor cells by induction of carbonyl reductase. Biochem Pharmacol 59:293–300
4. Biroccio A, Benassi B, Amodei S, Gabellini C, Del Bufalo D, Zupi G (2001) c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells. Mol Pharmacol 60:174–182
5. Burczynski ME, Lin HK, Penning TM (1999) Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res 59:607–614